Fund Holdings — B Group, Inc.

Total Portfolio Value:
$115.78M
Total Bought:
$8.81M
Total Sold:
$10.59M
Net Transaction:
-$1.78M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc2,317,5422,317,5420$45.98M$42.20M36.45%-$3.78M
Insmed Incorporated(INSM)262,500155,000-107,500$20.03M$15.60M13.47%-$4.43M
Zai Lab LimitedADR(ZLAB)400,000400,0000$14.46M$13.99M12.08%-$468.0K
Akero Therapeutics Inc242,500232,446-10,054$9.82M$12.40M10.71%+$2.59M
Cellectis S.A.ADS(CLLS)3,256,5013,256,5010$4.04M$4.97M4.29%+$928.1K
Taysha Gene Therapies, Inc.(TSHA)1,255,5561,800,556+545,000$1.75M$4.16M3.59%+$2.41M
Ultragenyx Pharmaceutical Inc.(RARE)47,500110,000+62,500$1.72M$4.00M3.45%+$2.28M
Sight Sciences, Inc.(SGHT)833,600930,000+96,400$2.00M$3.84M3.32%+$1.84M
Aura Biosciences, Inc.(AURA)472,576572,576+100,000$2.77M$3.58M3.10%+$815.0K
Assembly Biosciences Inc200,000189,350-10,650$1.91M$3.43M2.96%+$1.52M
Iovance Biotherapeutics, Inc.(IOVA)1,500,0001,500,0000$5.00M$2.58M2.23%-$2.42M
Apogee Therapeutics Inc30,00035,000+5,000$1.12M$1.52M1.31%+$399.3K
Praxis Precision Medicines, Inc.(PRAX)19,00035,000+16,000$719.5K$1.47M1.27%+$752.2K
Spyre Therapeutics, Inc.(SYRE)70,00080,000+10,000$1.13M$1.20M1.03%+$68.2K
Oruka Therapeutics, Inc.(ORKA)58,21575,000+16,785$597.3K$840.8K0.73%+$243.5K
89bio Inc95,6230-95,623$695.2K$0—-$695.2K
BioNTech SEADS(BNTX)15,0000-15,000$1.37M$0—-$1.37M
Page 1 of 1
B Group, Inc. — 13F Holdings — Q2 2025 | TickerTrail